Ad
related to: budwig protocol for secondary immunodeficiency cancer
Search results
Results From The WOW.Com Content Network
Johanna Budwig (1908 – 2003) was a German biochemist, alternative cancer treatment advocate and writer. [1] Budwig was a pharmacist and held doctorate degrees in physics and chemistry . [ 2 ] Based on her research on fatty acids she developed a lacto-vegetarian diet that she believed was useful in the treatment of cancer .
Budwig protocol (or Budwig diet) – an "anti-cancer" diet developed in the 1950s by Johanna Budwig (1908–2003). The diet is rich in flaxseed oil mixed with cottage cheese, and emphasizes meals high in fruit, vegetables and fiber; it avoids sugar, animal fats, salad oil, meats, butter and especially margarine. Cancer Research UK say, "there ...
A number of specific diets and diet-based regimes have been claimed to be useful against cancer, including the Breuss diet, Gerson therapy, the Budwig protocol and the macrobiotic diet. None of these diets has been found to be effective, and some of them have been found to be harmful. [16]
Immunoglobulin therapy is the use of a mixture of antibodies (normal human immunoglobulin) to treat several health conditions. [13] [14] These conditions include primary immunodeficiency, immune thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain–Barré syndrome, and certain other infections when a ...
In patients with breast cancer, levels of MDSC in blood are about 10-fold higher than normal. [6] The size of the myeloid suppressor compartment is considered to be an important factor in the success or failure of cancer immunotherapy, highlighting the importance of this cell type for human pathophysiology. [7]
The next step in cancer immunoediting is the equilibrium phase, during which tumor cells that have escaped the elimination phase and have a non-immunogenic phenotype are selected for growth. Lymphocytes and IFN-gamma exert a selection pressure on tumor cells which are genetically unstable and rapidly mutating.
The use of high-dosage intravenous ascorbic acid as a cancer treatment was first promoted by Linus Pauling and Ewan Cameron in the 1970s; [25] [26] however, these findings were not reproduced using oral administration by subsequent Mayo Clinic studies in the 1980s.
Primary central nervous system lymphoma (PCNSL), also termed primary diffuse large B-cell lymphoma of the central nervous system (DLBCL-CNS), [2] is a primary intracranial tumor appearing mostly in patients with severe immunodeficiency (typically patients with AIDS). It is a subtype and one of the most aggressive of the diffuse large B-cell ...